retatrutide 2025 trial results This is exciting. 👀 The TRIUMPH-4 for Lilly's investigational medication were released, showing weight loss of up to 71 lbs (~28%) over 68 weeks in the highest-dose group—far beyond I personally know plenty of

What Makes This Formula Special

With Amazon officially stepping into the GLP-1 space , access to treatments like semaglutide and tirzepatide is becoming faster, more digital, and more mainstream than ever before

Potential Risks: Conversely, other studies indicate that GLP-1 receptor agonists might increase the risk of developing colorectal cancer

A pesar de la baja incidencia de estos eventos adversos y de la probabilidad de que los beneficios superen estos riesgos en los individuos con obesidad grave, los mdicos y los pacientes deben ser conscientes de estos efectos secundarios graves

Buyers should ask their assigned provider directly about the specific medication, dosage protocol, and titration schedule before starting - because the titration timeline (how quickly your dose increases toward a therapeutic target) affects both tolerability and expected timeline to meaningful weight change

[ Editor's note: After MH went to press, Jelly clarified that he did briefly try weight-loss meds very early on his journey, but stopped after two weeks.] We talked for several hours at intervals over the course of this year about how he was doing it, and how he did it